ANIP - ANI Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts3333
Avg. Estimate0.991.123.844.56
Low Estimate0.981.073.784.4
High Estimate11.153.884.71
Year Ago EPS1.090.843.783.84
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts3333
Avg. Estimate48.12M52.72M182.1M216.73M
Low Estimate47.47M51.22M180.08M205.9M
High Estimate48.5M53.5M183.23M226M
Year Ago Sales38.52M38.2M128.62M182.1M
Sales Growth (year/est)24.90%38.00%41.60%19.00%
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.1.081.090.770.86
EPS Actual1.090.840.740.98
Difference0.01-0.25-0.030.12
Surprise %0.90%-22.90%-3.90%14.00%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate0.991.123.844.56
7 Days Ago0.991.123.844.56
30 Days Ago0.991.123.844.56
60 Days Ago0.991.123.844.56
90 Days Ago1.041.193.844.61
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesANIPIndustrySectorS&P 500
Current Qtr.-9.20%N/AN/A0.17
Next Qtr.33.30%N/AN/A0.27
Current Year1.60%N/AN/A0.07
Next Year18.80%N/AN/A0.12
Next 5 Years (per annum)13.30%N/AN/A0.10
Past 5 Years (per annum)32.55%N/AN/AN/A